tradingkey.logo
tradingkey.logo
検索

QuidelOrtho Corp

QDEL
ウォッチリストに追加
18.250USD
+0.070+0.39%
終値 07/02, 13:00ET15分遅れの株価
1.24B時価総額
損失額直近12ヶ月PER

詳細情報 QuidelOrtho Corp 企業名

QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.

QuidelOrtho Corpの企業情報

企業コードQDEL
会社名QuidelOrtho Corp
上場日Feb 01, 1991
最高経営責任者「CEO」Blaser (Brian J)
従業員数6600
証券種類Ordinary Share
決算期末Feb 01
本社所在地9975 Summers Ridge Road
都市SAN DIEGO
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号92121
電話番号18585521100
ウェブサイトhttps://www.quidelortho.com/
企業コードQDEL
上場日Feb 01, 1991
最高経営責任者「CEO」Blaser (Brian J)

QuidelOrtho Corpの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Kenneth F. Buechler, Ph.D.
Dr. Kenneth F. Buechler, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
113.39K
+1.90%
Dr. Matthew W. Strobeck, Ph.D.
Dr. Matthew W. Strobeck, Ph.D.
Independent Director
Independent Director
89.38K
+7.64%
Mr. Brian J. Blaser
Mr. Brian J. Blaser
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
75.72K
+13.88%
Mr. Joseph M. Busky
Mr. Joseph M. Busky
Chief Financial Officer
Chief Financial Officer
55.11K
+14.77%
Ms. Michelle A. Hodges, J.D.
Ms. Michelle A. Hodges, J.D.
Senior Vice President, Corporate Secretary, Chief Legal Officer
Senior Vice President, Corporate Secretary, Chief Legal Officer
43.18K
+4.96%
Mr. Edward L. (Ed) Michael
Mr. Edward L. (Ed) Michael
Independent Director
Independent Director
29.43K
+4.25%
Ms. Ann D. Rhoads
Ms. Ann D. Rhoads
Independent Director
Independent Director
23.26K
+35.41%
Mr. John R. Chiminski
Mr. John R. Chiminski
Independent Director
Independent Director
9.35K
+73.02%
Dr. Mary Lake Polan, M.D., Ph.D.
Dr. Mary Lake Polan, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Kenneth Jon (Ken) Widder, M.D.
Dr. Kenneth Jon (Ken) Widder, M.D.
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Kenneth F. Buechler, Ph.D.
Dr. Kenneth F. Buechler, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
113.39K
+1.90%
Dr. Matthew W. Strobeck, Ph.D.
Dr. Matthew W. Strobeck, Ph.D.
Independent Director
Independent Director
89.38K
+7.64%
Mr. Brian J. Blaser
Mr. Brian J. Blaser
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
75.72K
+13.88%
Mr. Joseph M. Busky
Mr. Joseph M. Busky
Chief Financial Officer
Chief Financial Officer
55.11K
+14.77%
Ms. Michelle A. Hodges, J.D.
Ms. Michelle A. Hodges, J.D.
Senior Vice President, Corporate Secretary, Chief Legal Officer
Senior Vice President, Corporate Secretary, Chief Legal Officer
43.18K
+4.96%
Mr. Edward L. (Ed) Michael
Mr. Edward L. (Ed) Michael
Independent Director
Independent Director
29.43K
+4.25%

よくある質問

QuidelOrtho Corpの上位5名の株主は誰ですか?

QuidelOrtho Corpの上位5名の株主は以下のとおりです。Dr. Kenneth F. Buechler, Ph.D.

QuidelOrtho Corp(QDEL)の株式を保有している機関の数はいくつですか?

2026Q1時点で、QuidelOrtho Corpの株式を保有している機関は619社あり、保有株式の総市場価値は約88.33Mで、全体の129.53%を占めています。2025Q4と比較して、機関の持ち株は-14180850.00増加しています。

QuidelOrtho Corpの最大の収益源は何ですか?

2026Q1において、Labs部門がQuidelOrtho Corpにとって最大の収益を生み出しており、その金額は373.80Mで、全収益の53.41%を占めています。